MINNEAPOLIS, April 1, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative tools and bioactive reagents for the research and clinical diagnostic communities ...
MINNEAPOLIS, Oct. 16, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of proteins, antibodies and Immunoassays today announced that its Wallingford, CT facility has ...
For example, Bio-Techne’s consumable reagents can be used to build custom enzyme-linked immunosorbent assays (ELISA) and the firm offers a full range of reagents for researchers, ranging from ready-to ...
Next-generation biomarker discovery and diagnostics Bio-Techne combines expertise in exosome technologies with experience in the non-invasive liquid biopsy market to create solutions for companion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results